The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1

Yimei Qian, Lakshmi A. Devi, Nino Mzhavia, Scott Munzer, Nabil G. Seidah, Lloyd D. Fricker

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

ProSAAS is a recently discovered 26-kDa neuroendocrine protein that was previously found to inhibit pro-hormone convertase (PC) 1 and not PC2. In the present study, the specificity of proSAAS toward other members of the prohormone convertase family was determined. Two μM proSAAS selectively inhibits PC1 but not furin, PACE4, PC5A, or PC7. The PC1 inhibitory region of proSAAS was mapped to an 8-12-residue region near the C terminus that includes a critical Lys-Arg sequence. Synthetic peptides corresponding to this region are competitive inhibitors of PC1 with apparent K(i) values of 14-40 nM. The inhibition becomes more effective with incubation time, indicating that the inhibitor is slow binding. A fusion protein containing the inhibitory region of proSAAS linked to the C terminus of glutathione S-transferase binds the 71-kDa form but not the 85-kDa form of PC1. This binding, which occurs at pH 5.5 and not at pH 7.4, is stable to incubation at room temperature for I h in the presence or absence of 0.5% Triton X-100 and/or 0.5 M NaCl The removal of Ca2+ with chelating agents partially releases the bound PC1. High concentrations of the inhibitory peptide quantitatively release the bound PC1. Taken together, these data support the proposal that proSAAS functions as an endogenous inhibitor of PC1.

Original languageEnglish (US)
Pages (from-to)23596-23601
Number of pages6
JournalJournal of Biological Chemistry
Volume275
Issue number31
DOIs
StatePublished - Aug 4 2000

Fingerprint

Proprotein Convertase 1
Proprotein Convertases
Furin
Peptides
Octoxynol
Chelating Agents
Glutathione Transferase
Proteins
Fusion reactions
Hormones
Temperature

ASJC Scopus subject areas

  • Biochemistry

Cite this

The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. / Qian, Yimei; Devi, Lakshmi A.; Mzhavia, Nino; Munzer, Scott; Seidah, Nabil G.; Fricker, Lloyd D.

In: Journal of Biological Chemistry, Vol. 275, No. 31, 04.08.2000, p. 23596-23601.

Research output: Contribution to journalArticle

Qian, Yimei ; Devi, Lakshmi A. ; Mzhavia, Nino ; Munzer, Scott ; Seidah, Nabil G. ; Fricker, Lloyd D. / The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1. In: Journal of Biological Chemistry. 2000 ; Vol. 275, No. 31. pp. 23596-23601.
@article{dc6ae19f315740928a90166bc37abadc,
title = "The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1",
abstract = "ProSAAS is a recently discovered 26-kDa neuroendocrine protein that was previously found to inhibit pro-hormone convertase (PC) 1 and not PC2. In the present study, the specificity of proSAAS toward other members of the prohormone convertase family was determined. Two μM proSAAS selectively inhibits PC1 but not furin, PACE4, PC5A, or PC7. The PC1 inhibitory region of proSAAS was mapped to an 8-12-residue region near the C terminus that includes a critical Lys-Arg sequence. Synthetic peptides corresponding to this region are competitive inhibitors of PC1 with apparent K(i) values of 14-40 nM. The inhibition becomes more effective with incubation time, indicating that the inhibitor is slow binding. A fusion protein containing the inhibitory region of proSAAS linked to the C terminus of glutathione S-transferase binds the 71-kDa form but not the 85-kDa form of PC1. This binding, which occurs at pH 5.5 and not at pH 7.4, is stable to incubation at room temperature for I h in the presence or absence of 0.5{\%} Triton X-100 and/or 0.5 M NaCl The removal of Ca2+ with chelating agents partially releases the bound PC1. High concentrations of the inhibitory peptide quantitatively release the bound PC1. Taken together, these data support the proposal that proSAAS functions as an endogenous inhibitor of PC1.",
author = "Yimei Qian and Devi, {Lakshmi A.} and Nino Mzhavia and Scott Munzer and Seidah, {Nabil G.} and Fricker, {Lloyd D.}",
year = "2000",
month = "8",
day = "4",
doi = "10.1074/jbc.M001583200",
language = "English (US)",
volume = "275",
pages = "23596--23601",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "31",

}

TY - JOUR

T1 - The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1

AU - Qian, Yimei

AU - Devi, Lakshmi A.

AU - Mzhavia, Nino

AU - Munzer, Scott

AU - Seidah, Nabil G.

AU - Fricker, Lloyd D.

PY - 2000/8/4

Y1 - 2000/8/4

N2 - ProSAAS is a recently discovered 26-kDa neuroendocrine protein that was previously found to inhibit pro-hormone convertase (PC) 1 and not PC2. In the present study, the specificity of proSAAS toward other members of the prohormone convertase family was determined. Two μM proSAAS selectively inhibits PC1 but not furin, PACE4, PC5A, or PC7. The PC1 inhibitory region of proSAAS was mapped to an 8-12-residue region near the C terminus that includes a critical Lys-Arg sequence. Synthetic peptides corresponding to this region are competitive inhibitors of PC1 with apparent K(i) values of 14-40 nM. The inhibition becomes more effective with incubation time, indicating that the inhibitor is slow binding. A fusion protein containing the inhibitory region of proSAAS linked to the C terminus of glutathione S-transferase binds the 71-kDa form but not the 85-kDa form of PC1. This binding, which occurs at pH 5.5 and not at pH 7.4, is stable to incubation at room temperature for I h in the presence or absence of 0.5% Triton X-100 and/or 0.5 M NaCl The removal of Ca2+ with chelating agents partially releases the bound PC1. High concentrations of the inhibitory peptide quantitatively release the bound PC1. Taken together, these data support the proposal that proSAAS functions as an endogenous inhibitor of PC1.

AB - ProSAAS is a recently discovered 26-kDa neuroendocrine protein that was previously found to inhibit pro-hormone convertase (PC) 1 and not PC2. In the present study, the specificity of proSAAS toward other members of the prohormone convertase family was determined. Two μM proSAAS selectively inhibits PC1 but not furin, PACE4, PC5A, or PC7. The PC1 inhibitory region of proSAAS was mapped to an 8-12-residue region near the C terminus that includes a critical Lys-Arg sequence. Synthetic peptides corresponding to this region are competitive inhibitors of PC1 with apparent K(i) values of 14-40 nM. The inhibition becomes more effective with incubation time, indicating that the inhibitor is slow binding. A fusion protein containing the inhibitory region of proSAAS linked to the C terminus of glutathione S-transferase binds the 71-kDa form but not the 85-kDa form of PC1. This binding, which occurs at pH 5.5 and not at pH 7.4, is stable to incubation at room temperature for I h in the presence or absence of 0.5% Triton X-100 and/or 0.5 M NaCl The removal of Ca2+ with chelating agents partially releases the bound PC1. High concentrations of the inhibitory peptide quantitatively release the bound PC1. Taken together, these data support the proposal that proSAAS functions as an endogenous inhibitor of PC1.

UR - http://www.scopus.com/inward/record.url?scp=0034604618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034604618&partnerID=8YFLogxK

U2 - 10.1074/jbc.M001583200

DO - 10.1074/jbc.M001583200

M3 - Article

C2 - 10816562

AN - SCOPUS:0034604618

VL - 275

SP - 23596

EP - 23601

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 31

ER -